miRNA

Open Access
LET-7a and LET-7b as Potential Signatures for Glioma Recurrence, Regardless of WHO Tumor Grade
SYLVIE WEBER, SASKIA KUHL, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research December 2024, 44 (12) 5199-5205; DOI: https://doi.org/10.21873/anticanres.17346
You have access
Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SHIGEKI SATO, HIROYUKI SAKAGUCHI, KOJI FUKUDA, HIROSHI KOTANI, AKIHIRO NISHIYAMA, SHIGEKI NANJO, KANAME YAMASHITA, SHINJI TAKEUCHI, SEIJI YANO, SAWAKO KURUMA, JUN NAKAHODO, MASATAKA KIKUYAMA and HIROAKI TANIGUCHI

Anticancer Research December 2024, 44 (12) 5253-5261; DOI: https://doi.org/10.21873/anticanres.17353
You have access
Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral Squamous Cell Carcinoma via FAK/P53 Signaling Axis
CHE-HSUAN LIN, CHIH-CHIU CHIANG, YA-CHI SHIH, SHIAO-LIN TUNG and WEI-CHIEH HUANG

Anticancer Research June 2024, 44 (6) 2517-2531; DOI: https://doi.org/10.21873/anticanres.17058
You have access
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE

Anticancer Research May 2024, 44 (5) 2081-2089; DOI: https://doi.org/10.21873/anticanres.17012
You have access
Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis
YING-HAO HAN, YUAN WANG, SEUNG-JAE LEE, YING-YING MAO, PENG JIANG, HU-NAN SUN, MEI-HUA JIN and TAEHO KWON

Anticancer Research July 2023, 43 (7) 2951-2964; DOI: https://doi.org/10.21873/anticanres.16466
Open Access
Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN

Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
You have access
Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors
STEFAN PYCHA, CAROLINA D’ELIA, CHRISTINE MIAN, CHRISTINE SCHWIENBACHER, ESTHER HANSPETER, MARGHERITA PALERMO, ARMIN PYCHA, HANSJÖRG DANUSER and EMANUELA TRENTI

Anticancer Research April 2023, 43 (4) 1649-1653; DOI: https://doi.org/10.21873/anticanres.16316
You have access
Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma
MAHYAR SHARIF BAGHERI, JIRI POLIVKA, INKA TRESKOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, VLASTIMIL WOZNICA, TOMAS FIKRLE, KRISTYNA PIVOVARCIKOVA, MARTIN SVATON, DATTATRYA SHETTI, RASHMI NEGI and MARTIN PESTA

Anticancer Research February 2023, 43 (2) 695-706; DOI: https://doi.org/10.21873/anticanres.16208
You have access
Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
DAMIAN J. RALSER, MATEJA CONDIC, EVA EGGER, DOMINIQUE KOENSGEN, ALEXANDER MUSTEA and MATTHIAS B. STOPE

Anticancer Research December 2022, 42 (12) 5839-5845; DOI: https://doi.org/10.21873/anticanres.16092
Open Access
Cell Dissociation Enzymes Affect Annexin V/Flow-Cytometric Apoptotic Assay Outcomes After miRNA-based Transient Transfection
CHRISTINA M. GOBIN, JAMES N. MENEFEE, CHAYIL C. LATTIMORE, ANDRIA DOTY and KRISTIANNA M. FREDENBURG

Anticancer Research June 2022, 42 (6) 2819-2825; DOI: https://doi.org/10.21873/anticanres.15763

Main menu

User menu

Search

miRNA

Pages